Rewriting cancer’s code: A micropeptide’s mitochondrial mission
Molecular Cell · 2025
DOI: 10.1016/j.molcel.2025.05.034 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Cell, 2025. Verfasst von George A Calin und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cancer Biology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Translational Molecular Pathology,…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, RNA, Long Noncoding, Mitochondria. Die Arbeit nennt 9 Literaturangaben.
Abstract (Originalsprache)
In this issue of Molecular Cell, Zhu et al.1 uncover a lncRNA-derived micropeptide that disrupts mitochondrial RNA processing, revealing a new layer of metabolic vulnerability in hepatocellular carcinoma (HCC).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Cancer Biology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA…
- Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Zitieren
APA
Calin, G. A., & Visal, T. H. (2025). Rewriting cancer’s code: A micropeptide’s mitochondrial mission. Molecular Cell. https://doi.org/10.1016/j.molcel.2025.05.034
Vancouver
Calin GA, Visal TH. Rewriting cancer’s code: A micropeptide’s mitochondrial mission. Molecular Cell. 2025. doi:10.1016/j.molcel.2025.05.034
BibTeX
@article{Calin2025,
author = {Calin, George A and Visal, Tanvi H},
title = {Rewriting cancer’s code: A micropeptide’s mitochondrial mission},
journal = {Molecular Cell},
year = {2025},
doi = {10.1016/j.molcel.2025.05.034}
}
EUVIMED